跳至主要内容
临床试验/ISRCTN18238432
ISRCTN18238432已完成不适用

Bronchiolitis randomised controlled trial (RCT): Emergency Assisted Therapy with Heliox - an Evaluatio

Imperial College London (UK)0 个研究点目标入组 298 人开始时间: 2005年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
298

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Chronological age = 1 year or less
  • 2. Bronchiolitis likely as a diagnosis
  • 3. Requiring admission for treatment of respiratory distress or hypoxia (i.e. SpO2 <93%)

排除标准

  • 1. Any condition requiring immediate intubation (including apnoea or bradycardia)
  • 2. Unable to maintain SpO2 >92% despite 15 l/min oxygen
  • 3. Legal incapacity of parent/guardian to give consent
  • 4. Participating in another drug trial in the past 4 weeks
  • 5. Inappropriate for child to enter study, in clinician's opinion
  • 6. Child has a tracheostomy
  • 7. Readmitted (with a diagnosis of bronchiolitis) within 24 hours of exiting from the BREATHE study
  • 8. If any of the following drugs were given prior to entry/enrolment into the BREATHE study:
  • a. Salbutamol or ipratropium/atrovent (less than 1 hour prior to entry into BREATHE)
  • b. Adrenaline (less than 1 hour prior to entry into BREATHE)
  • c. Systemic steroids (less than 4 hours prior to entry into BREATHE)

研究者

发起方
Imperial College London (UK)

相似试验